Evaluating the Humoral Immune Response to Sinovac-Coronavac in a Pediatric Patient with Propionic Acidemia: A Case Study.
作者信息
Ergün İlayda, Dinç Harika Öykü, Burtecene Nihan, Kıykım Ertuğrul, Aktuğlu-Zeybek Çiğdem, Cansever Mehmet Şerif, Kıykım Ayça, Kocazeybek Bekir, Zubarioglu Tanyel
机构信息
Department of Pediatrics, İstanbul University-Cerrahpaşa Cerrahpaşa Medical Faculty, İstanbul, Türkiye.
Department of Medical Microbiology, Üsküdar University Faculty of Medicine, İstanbul, Türkiye.
出版信息
Turk Arch Pediatr. 2025 Jul 1;60(4):440-442. doi: 10.5152/TurkArchPediatr.2025.25082.
Abstract
摘要
相似文献
1
Evaluating the Humoral Immune Response to Sinovac-Coronavac in a Pediatric Patient with Propionic Acidemia: A Case Study.评估丙酸血症患儿对科兴新冠疫苗的体液免疫反应：一项病例研究。
Turk Arch Pediatr. 2025 Jul 1;60(4):440-442. doi: 10.5152/TurkArchPediatr.2025.25082.
2
A 20-month longitudinal study to evaluate humoral and cellular immunity after COVID-19 vaccines.一项评估新冠疫苗接种后体液免疫和细胞免疫的20个月纵向研究。
Mem Inst Oswaldo Cruz. 2025 Jul 18;120:e240193. doi: 10.1590/0074-02760240193. eCollection 2025.
3
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.在儿童和青少年中使用两剂基础免疫方案的灭活严重急性呼吸综合征冠状病毒2疫苗（科兴新冠疫苗）的免疫原性和安全性（Immunita-002，巴西）：IV期六个月随访
Res Sq. 2024 Feb 29:rs.3.rs-3931021. doi: 10.21203/rs.3.rs-3931021/v1.
4
The Acidemia Index: A Near Real-Time Risk Analytics Algorithm is Associated With Measured Acidemia in Pediatric Critical Care Patients, a Multi-Center Validation Study.酸血症指数：一种近实时风险分析算法与儿科重症监护患者的实测酸血症相关，一项多中心验证研究。
Crit Care Explor. 2025 Jun 25;7(7):e1281. doi: 10.1097/CCE.0000000000001281. eCollection 2025 Jul 1.
5
[Sequential therapy with carglumic acid in three cases of organic acidemia crisis].[三例有机酸血症危象患者使用卡谷氨酸的序贯治疗]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jul 15;27(7):850-853. doi: 10.7499/j.issn.1008-8830.2412043.
6
Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals.新冠病毒吸附灭活疫苗（科兴中维/布坦坦；克尔来福）两剂接种方案以及免疫功能低下和免疫功能正常个体中异源追加剂量的mRNA BNT162b2（辉瑞/生物科技）的安全性。
Rev Inst Med Trop Sao Paulo. 2025 Jan 20;67:e2. doi: 10.1590/S1678-9946202567002. eCollection 2025.
8
An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.基于 mRNA 的疗法治疗英国甲基丙二酸血症和丙酸血症的早期成本效用模型。
Clin Drug Investig. 2024 Jun;44(6):399-412. doi: 10.1007/s40261-024-01363-1. Epub 2024 May 25.
9
Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Türkiye.土耳其科兴疫苗（CoronaVac）和BNT162b2疫苗不同加强免疫策略后的定量免疫球蛋白G和干扰素-γ反应
Infect Dis Clin Microbiol. 2025 Jun 26;7(2):156-165. doi: 10.36519/idcm.2025.546. eCollection 2025 Jun.
10
Efficacy and safety of COVID-19 vaccines.新型冠状病毒疫苗的有效性和安全性。
Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477.
本文引用的文献
1
Hypogammaglobulinemia Class G Is Present in Compensated and Decompensated Patients with Propionate Defects, Independent of Their Nutritional Status.γ-球蛋白血症 G 类存在于丙酸缺陷的代偿和失代偿患者中，与他们的营养状况无关。
Nutrients. 2024 Jun 5;16(11):1775. doi: 10.3390/nu16111775.
2
Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects.遗传性代谢疾病的临床和生化特征。十二、免疫缺陷。
Mol Genet Metab. 2023 May;139(1):107582. doi: 10.1016/j.ymgme.2023.107582. Epub 2023 Apr 17.
3
Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients.免疫功能低下患者 COVID-19 疫苗接种的安全性和免疫原性。
Chin Med J (Engl). 2022 Nov 20;135(22):2656-2666. doi: 10.1097/CM9.0000000000002505.
4
BNT162b2 COVID-19 vaccination elicited protective robust immune responses in pediatric patients with inborn errors of metabolism.BNT162b2 COVID-19 疫苗在患有先天性代谢缺陷的儿科患者中引发了保护性的强烈免疫反应。
Front Immunol. 2023 Jan 5;13:1082192. doi: 10.3389/fimmu.2022.1082192. eCollection 2022.
5
COVID-19 Vaccine in Inherited Metabolic Disorders Patients: A Cross-Sectional Study on Rate of Acceptance, Safety Profile and Effect on Disease.遗传性代谢疾病患者的 COVID-19 疫苗：接受率、安全性概况及其对疾病影响的横断面研究。
Int J Environ Res Public Health. 2022 Sep 27;19(19):12227. doi: 10.3390/ijerph191912227.
6
Immunological Memory and Affinity Maturation After Vaccination in Patients With Propionic Acidemia.丙酸血症患者接种疫苗后的免疫记忆和亲和力成熟。
Front Immunol. 2022 Mar 25;13:774503. doi: 10.3389/fimmu.2022.774503. eCollection 2022.
7
Altered immune response in organic acidemia.有机酸血症中的免疫应答改变。
Pediatr Int. 2022 Jan;64(1):e15082. doi: 10.1111/ped.15082.
8
Reference values for T and B lymphocyte subpopulations in Turkish children and adults.土耳其儿童和成人 T 及 B 淋巴细胞亚群参考值。
Turk J Med Sci. 2021 Aug 30;51(4):1814-1824. doi: 10.3906/sag-2010-176.
9
Inborn errors of immunity and metabolic disorders: current understanding, diagnosis, and treatment approaches.先天性免疫和代谢紊乱：当前的认识、诊断和治疗方法。
J Pediatr Endocrinol Metab. 2020 Dec 16;34(3):277-294. doi: 10.1515/jpem-2020-0277. Print 2021 Mar 26.
10
Abnormalities in subsets of B and T cells in Mexican patients with inborn errors of propionate metabolism: observations from a single-center case series.墨西哥先天性丙酸代谢异常患者的 B 和 T 细胞亚群异常：来自单中心病例系列的观察结果。
Allergol Immunopathol (Madr). 2021 Jan 2;49(1):101-106. doi: 10.15586/aei.v49i1.27. eCollection 2021.
Zotero 插件